Evolved bacterial siderophore-mediated antibiotic cross-protection

Antibiotic cross-protection enables resistant bacteria to protect other bacteria that would be otherwise susceptible to the drug. Cefiderocol is the first siderophore cephalosporin antibiotic approved for treating Gram-negative bacterial infections, including carbapenem-resistant Pseudomonas aerugin...

Descripción completa

Detalles Bibliográficos
Autores principales: Galdino, Anna Clara M., Vaillancourt, Mylene, Celedonio, Diana, Huse, Kara, Doi, Yohei, Lee, Janet S., Jorth, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246284/
https://www.ncbi.nlm.nih.gov/pubmed/37292841
http://dx.doi.org/10.21203/rs.3.rs-2644953/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246284/
https://www.ncbi.nlm.nih.gov/pubmed/37292841
http://dx.doi.org/10.21203/rs.3.rs-2644953/v1

Ejemplares similares